Enfermedades neurodegenerativas: mecanismos patogénicos
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Sanchez D, Bajo-Grañeras R, Del Caño-Espinel M, Garcia-Centeno R, Garcia-Mateo N, Pascua-Maestro R, Ganfornina MD.
Aging without Apolipoprotein D: Molecular and cellular modifications in the hippocampus and cortex
EXPERIMENTAL GERONTOLOGY . 67: 19-47. Nº de citas: 24
-
Stern CA, Gazarini L, Vanvossen AC, Zuardi AW, Galve-Roperh I, Guimaraes FS, Takahashi RN, Bertoglio LJ.
Delta(9)-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 25(6): 958-965. Nº de citas: 42
-
Abrams DI, Guzman M.
Cannabis in Cancer Care
CLINICAL PHARMACOLOGY & THERAPEUTICS . 97(6): 575-586. Nº de citas: 111
-
Pérez-Gómez E, Andradas C, Blasco-Benito S, Caffarel MM, García-Taboada E, Villa-Morales M, Moreno E, Hamann S, Martín-Villar E, Flores JM, Wenners A, Alkatout I, Klapper W, Röcken C, Bronsert P, Stickeler E, Staebler A, Bauer M, Arnold N, Soriano J, Pérez-Martínez M, Megías D, Moreno-Bueno G, Ortega-Gutiérrez S, Artola M, Vázquez-Villa H, Quintanilla M, Fernández-Piqueras J, Canela EI, McCormick PJ, Guzmán M, Sánchez C.
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE . 107(6): . Nº de citas: 67
-
Oddi D, Subashi E, Middei S, Bellocchio L, Lemaire-Mayo V, Guzmán M, Crusio WE, D'Amato FR, Pietropaolo S.
Early Social Enrichment Rescues Adult Behavioral and Brain Abnormalities in a Mouse Model of Fragile X Syndrome
NEUROPSYCHOPHARMACOLOGY . 40(5): 1113-1122. Nº de citas: 62
-
Garcez PP, Diaz-Alonso J, Crespo-Enriquez I, Castro D, Bell D, Guillemot F.
Cenpj/CPAP regulates progenitor divisions and neuronal migration in the cerebral cortex downstream of Ascl1
NATURE COMMUNICATIONS . 6: 6474-6474. Nº de citas: 37
-
Cardinal P, Bellocchio L, Guzmán-Quevedo O, André C, Clark S, Elie M, Leste-Lasserre T, Gonzales D, Cannich A, Marsicano G, Cota D.
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice
Endocrinology . 156(2): 411-418. Nº de citas: 31
-
Pietropaolo S, Bellocchio L, Ruiz-Calvo A, Cabanas M, Du Z, Guzmán M, Garret M, Cho YH.
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease
Neuropharmacology . 89: 368-374. Nº de citas: 21
-
Velasco G, Sánchez C, Guzmán M.
Endocannabinoids and Cancer.
Handbook of experimental pharmacology . 231: 449-472.
-
Crespo-Sanjuán J, Calvo-Nieves MD, Aguirre-Gervás B, Herreros-Rodríguez J, Velayos-Jiménez B, Castro-Alija MJ, Muñoz-Moreno MF, Sánchez D, Zamora-González N, Bajo-Grañeras R, García-Centeno RM, Largo Cabrerizo ME, Bustamante MR, Garrote-Adrados JA.
Early Detection of High Oxidative Activity in Patients With Adenomatous Intestinal Polyps and Colorectal Adenocarcinoma: Myeloperoxidase and Oxidized Low-Density Lipoprotein in Serum as New Markers of Oxidative Stress in Colorectal Cancer
Labmedicine . 46(2): 123-135. Nº de citas: 18
-
Salazar M, Lorente M, García-Taboada E, Pérez Gómez E, Dávila D, Zúñiga-García P, María Flores J, Rodríguez A, Hegedus Z, Mosén-Ansorena D, Aransay AM, Hernández-Tiedra S, López-Valero I, Quintanilla M, Sánchez C, Iovanna JL, Dusetti N, Guzmán M, Francis SE, Carracedo A, Kiss-Toth E, Velasco G.
Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation
CELL DEATH AND DIFFERENTIATION . 22(1, SI): 131-144. Nº de citas: 61
-
Vicario-de-la-Torre M, Benítez-del-Castillo JM, Vico E, Guzmán M, de-Las-Heras B, Herrero-Vanrell R, Molina-Martínez IT.
Design and Characterization of an Ocular Topical Liposomal Preparation to Replenish the Lipids of the Tear Film
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 55(12): 7839-7847. Nº de citas: 38
-
Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T.
Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies
NATURE REVIEWS NEUROSCIENCE . 15(12): 786-801. Nº de citas: 180
-
Soria-Gomez E, Bellocchio L, Marsicano G.
New insights on food intake control by olfactory processes: The emerging role of the endocannabinoid system
MOLECULAR AND CELLULAR ENDOCRINOLOGY . 397(1-2, SI): 59-66. Nº de citas: 27
-
Cardinal P, André C, Quarta C, Bellocchio L, Clark S, Elie M, Leste-Lasserre T, Maitre M, Gonzales D, Cannich A, Pagotto U, Marsicano G, Cota D.
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
Molecular metabolism . 3(7): 705-716. Nº de citas: 54
-
Guzmán M, Sabbione F, Gabelloni ML, Vanzulli S, Trevani AS, Giordano MN, Galletti JG.
Restoring Conjunctival Tolerance by Topical Nuclear Factor-kappa B Inhibitors Reduces Preservative-Facilitated Allergic Conjunctivitis in Mice
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 55(9): 6116-6126. Nº de citas: 27
-
Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
JOURNAL OF BIOLOGICAL CHEMISTRY . 289(32): 21960-21972. Nº de citas: 71
-
Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 111(22): 8257-8262. Nº de citas: 109